Sunvet Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.71 Cr
- Company Age 23 Year, 13 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.88 Cr
- Satisfied Charges ₹ 2.06 Cr
- Revenue Growth -3.68%
- Profit Growth -69.46%
- Ebitda -23.85%
- Net Worth 1.92%
- Total Assets -6.18%
About Sunvet Pharma
Sunvet Pharma Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 January 2002 and has a history of 23 years. Its registered office is in Panchkula, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.71 Cr.
The company currently has active open charges totaling ₹2.88 Cr. The company has closed loans amounting to ₹2.06 Cr, as per Ministry of Corporate Affairs (MCA) records.
Naresh Kumar and Krishna Jha serve as directors at the Company.
Company Details
- Location
Panchkula, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24239HR2002PTC034816
- Company No.
034816
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2002
- Date of AGM
23 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Sunvet Pharma Private Limited offer?
Sunvet Pharma Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Cardiovascular Drugs & Medication, Cardiac Drugs, Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Animal Medicines & Health Care, Veterinary Medicines, Common Disease Medicines, Injectable Products.
Who are the key members and board of directors at Sunvet Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Kumar  | Director | 27-Jan-2008 | Current |
| Krishna Jha | Director | 14-Feb-2024 | Current |
Financial Performance of Sunvet Pharma.
Sunvet Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.68% decrease. The company also saw a substantial fall in profitability, with a 69.46% decrease in profit. The company's net worth moved up by a moderate rise of 1.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunvet Pharma?
In 2023, Sunvet Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mga Drugs Private LimitedNaresh Kumar is a mutual person
Charges (Loans)
₹2.88 Cr
₹2.06 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 2.88 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Oct 2007 | State Bank Of India | ₹2.88 Cr | Open |
| 21 Feb 2011 | Icici Bank Limited | ₹1.66 M | Satisfied |
| 27 Jul 2010 | State Bank Of India | ₹7.50 M | Satisfied |
| 20 Jan 2009 | Director Of Industries | ₹1.73 M | Satisfied |
| 08 Jul 2006 | Punjab National Bank | ₹9.70 M | Satisfied |
How Many Employees Work at Sunvet Pharma?
Sunvet Pharma has a workforce of 19 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunvet Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunvet Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
